Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
Dong Won Baek, Dae Young Kim, Sang Kyun Sohn, Youngil Koh, Sung-Hoon Jung, Ho-Young Yhim, Yunsuk Choi, Joon Ho Moon
Korean J Intern Med. 2021;36(6):1471-1485. Published online 2021 Sep 24 DOI: https://doi.org/10.3904/kjim.2021.028
Citations to this article as recorded by 
Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy
Jae-Ho Yoon, Seok Lee
The Korean Journal of Internal Medicine.2024; 39(1): 34. CrossRef
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study
Dong Won Baek, Han-Seung Park, Sang Kyun Sohn, Dae Young Kim, Inho Kim, Jae-Sook Ahn, Young Rok Do, Se Ryeon Lee, Hyeon-Seok Eom, Won-Sik Lee, Sung-Hyun Kim, Ho Sup Lee, Yoo Jin Lee, Joon Ho Moon, Je-Hwan Lee
The Korean Journal of Internal Medicine.2023; 38(5): 734. CrossRef
Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission
Han-zhou Qi, Jun Xu, Qian-qian Yang, Ren Lin, Zhi-xiang Wang, Ke Zhao, Qiang Wang, Xuan Zhou, Zhi-ping Fan, Fen Huang, Na Xu, Li Xuan, Hua Jin, Jing Sun, Robert Peter Gale, Hong-sheng Zhou, Qi-fa Liu
Bone Marrow Transplantation.2022; 57(11): 1704. CrossRef
Antineoplastics
Reactions Weekly.2022; 1926(1): 59. CrossRef